D110G (p.Asp110Gly) variant of RPE65 (Retinoid isomerohydrolase)
D110G (p.Asp110Gly) in RPE65 (Retinoid isomerohydrolase) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of RPE65-related recessive retinopathy. The available variant effect predictions contribute to a CATVariant prioritization score of 0.85 / 1. The record also includes population frequency data, published literature, and structural context.
D110G (p.Asp110Gly) variant details
- p.Asp110Gly
- rs1571170561
- ClinGen CA340748193
- ClinVar RCV000787882
- ClinVar RCV002535759
- Pathogenic
- RPE65-related recessive retinopathy
- Missense
- Variant Prioritization Score for Impact Estimate 0.847
- REVEL 0.94
- MetaLR 0.88
- MetaSVM 0.84
- CADD 31.00
- PolyPhen-2 0.98
- SIFT 0.00
- ClinVar: Pathogenic (RPE65-related recessive retinopathy)
- EBI: Pathogenic
- UniProt: Pathogenic
- Most common in the REMAINING population (allele frequency 1.7e-05)
- Structural context available
- Cited in: Nonsyndromic Leber Congenital Amaurosis / Early-Onset Severe Retinal Dystrophy Overview. (PMID 30285347)
- Cited in: Autosomal Recessive RPE65-Related Retinal Degeneration. (PMID 31725251)